Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies

Abstract

Liver biopsy rates are increasing likely owing to the changing epidemiology and management of common liver diseases. The similarity of the complication rate in our population-based study with estimates from specialized centres supports the safety of this important procedure.